BioCardia Inc Earnings: Miss on EPS

BioCardia Inc (BCDA) reported a quarterly loss of $0.21 per share on May 15, 2026, missing analyst estimates of $0.17 per share by 24.78%. The medical device company’s earnings per share came in significantly worse than expected, representing a negative surprise of approximately $0.04 per share.

The $0.21 loss per share exceeded Wall Street’s consensus estimate by nearly 25%, marking a disappointing quarter for the cardiovascular therapeutics company. Analysts had projected a smaller loss of $0.17 per share for the reporting period.

BioCardia’s actual EPS of negative $0.21 compared unfavorably to the estimated loss of $0.17, resulting in the 24.78% negative earnings surprise. The company did not report revenue figures for this quarterly period.

The earnings miss of $0.04 per share represents the difference between the actual loss of $0.21 and the expected loss of $0.17 per share.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.